`

NeuroSense Therapeutics

Biotechnology Research

Specialities :
Drug development
Als
Mnd
Lou gehrig's disease
Cns

+5

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$4.5M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About NeuroSense Therapeutics

What does Neurosense therapeutics do?+

Advancing research, development and therapy for ALS and additional CNS indications. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Currently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally. $NRSN

What are Neurosense therapeutics's specialties? +

Drug development,als,mnd,lou gehrig's disease,cns,biopharmaceuticals,neurodegenerative diseases,parkinson's disease,alzheimer's disease,and novel treatment

What is Neurosense therapeutics's industry? +

Neurosense therapeutics operates in the Biotechnology research industry.

What is Neurosense therapeutics's revenue? +

Neurosense therapeutics's revenue is 11m - 100m

What is Neurosense therapeutics's company size? +

Neurosense therapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free